LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 41.11 | 27.76 | 2101 | 3331 | 0.6307 | 0.8709 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 67.41 | 84.90 | 93 | 8766 | 0.0106 | 0.0137 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 42.81 | 27.76 | 111 | 3596 | 0.0309 | 0.2184 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 19.69 | 84.90 | 1263 | 1239 | 1.0190 | 1.0098 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 41.11 | 27.76 | 91 | 3331 | 0.0273 | 0.1876 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 23.10 | 84.90 | 12 | 1616 | 0.0074 | -0.3689 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 49.63 | 27.76 | 2850 | 4818 | 0.5915 | 0.8637 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 63.99 | 84.90 | 4836 | 8212 | 0.5889 | 0.8457 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 95.66 | 27.76 | 7726 | 6712 | 1.1510 | 1.0358 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 63.99 | 84.90 | 81 | 8212 | 0.0099 | -0.0071 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 95.66 | 27.76 | 1330 | 6712 | 0.1981 | 0.6302 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 19.69 | 84.90 | 7 | 1239 | 0.0056 | -0.4754 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 49.63 | 27.76 | 175 | 4818 | 0.0363 | 0.2808 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 65.70 | 84.90 | 86 | 8484 | 0.0101 | 0.0019 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 3.66 | 27.76 | 589 | 283 | 2.0745 | 1.4860 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 65.70 | 84.90 | 4969 | 8484 | 0.5857 | 0.8452 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 42.81 | 27.76 | 2243 | 3596 | 0.6237 | 0.8699 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 21.40 | 84.90 | 1370 | 1454 | 0.9418 | 0.9710 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 44.52 | 27.76 | 2400 | 3884 | 0.6179 | 0.8694 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 21.40 | 84.90 | 7 | 1454 | 0.0048 | -0.4560 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 44.52 | 27.76 | 130 | 3884 | 0.0335 | 0.2418 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 69.11 | 84.90 | 99 | 8988 | 0.0110 | 0.0231 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | C14 |
| MCF 10A-H2B-mCherry | Etoposide | 0.17783 | 26.51 | 84.90 | 15 | 1923 | 0.0078 | -0.3196 | MN20160318_Q02 | C14 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 46.22 | 27.76 | 2562 | 4125 | 0.6211 | 0.8722 | MN20160318_Q01 | C14 |